BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 130058)

  • 1. Practolol in acute myocardial infarction.
    Barber JM; Boyle DM; Chaturvedi NC; Singh N; Walsh MJ
    Acta Med Scand Suppl; 1976; 587():213-9. PubMed ID: 130058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modern doctoring.
    Best RA
    Clin Med (Lond); 2001; 1(2):154-5. PubMed ID: 11534486
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects on mortality during five years after early intervention with metoprolol in suspected acute myocardial infarction.
    Herlitz J; Hjalmarson A; Swedberg K; Rydén L; Waagstein F
    Acta Med Scand; 1988; 223(3):227-31. PubMed ID: 3281412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers for suspected or diagnosed acute myocardial infarction.
    Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class effect of beta-blockers in survivors of ST-elevation myocardial infarction: A nationwide cohort study using an insurance claims database.
    Lin TT; Arnold Chan K; Chen HM; Lai CL; Lai MS
    Sci Rep; 2015 Sep; 5():13692. PubMed ID: 26328923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing the right beta-blocker. A guide to selection.
    Hampton JR
    Drugs; 1994 Oct; 48(4):549-68. PubMed ID: 7528129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose propranolol for the protection of the left ventricle from ischaemic damage.
    Brown AH; Krause BL; Morritt GM
    Thorax; 1981 Nov; 36(11):814-22. PubMed ID: 7330803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease.
    Jürgensen HJ; Dalsgaard-Nielsen J; Kjøller E; Gormsen J
    Eur J Clin Pharmacol; 1981; 20(4):245-50. PubMed ID: 7030749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.
    Baber NS; Evans DW; Howitt G; Thomas M; Wilson T; Lewis JA; Dawes PM; Handler K; Tuson R
    Br Heart J; 1980 Jul; 44(1):96-100. PubMed ID: 7000100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
    Hansteen V; Møinichen E; Lorentsen E; Andersen A; Strøm O; Søiland K; Dyrbekk D; Refsum AM; Tromsdal A; Knudsen K; Eika C; Bakken J; Smith P; Hoff PI
    Br Med J (Clin Res Ed); 1982 Jan; 284(6310):155-60. PubMed ID: 6799077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.
    Gundersen T
    Br Heart J; 1983 Aug; 50(2):135-9. PubMed ID: 6224500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta adrenoceptor antagonists after myocardial infarction--where are we now?
    Chamberlain DA
    Br Heart J; 1983 Feb; 49(2):105-10. PubMed ID: 6130777
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary prevention of myocardial infarction: an uncertain feeling.
    Hart JT; Barley SL
    J R Coll Gen Pract; 1982 Nov; 32(244):651-3. PubMed ID: 6130149
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-blockade after myocardial infarction--a statistical view.
    Lewis JA
    Br J Clin Pharmacol; 1982; 14 Suppl 1(Suppl 1):15S-21S. PubMed ID: 6126204
    [No Abstract]   [Full Text] [Related]  

  • 15. Confidence in results of beta-blocker postinfarction trials.
    Baber NS; Lewis JA
    Br Med J (Clin Res Ed); 1982 Jun; 284(6331):1749-50. PubMed ID: 6123363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention in survivors of myocardial infarction. Joint Recommendations by the International Society and Federation of Cardiology, Scientific Councils on Arteriosclerosis, Epidemiology and Prevention, and Rehabilitation.
    Br Med J (Clin Res Ed); 1981 Mar; 282(6267):894-6. PubMed ID: 6111375
    [No Abstract]   [Full Text] [Related]  

  • 17. Sudden cardiac death, cardioprotection, and beta-adrenoceptor-blocking agents.
    Owens CW
    Br Med J; 1980 Aug; 281(6238):516-7. PubMed ID: 6107155
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium antagonists in secondary prevention after myocardial infarction.
    Persson S
    Drugs; 1991; 42 Suppl 2():54-60. PubMed ID: 1718702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The measurement and control of myocardial infarct size.
    Apps MC; Tinker J
    Intensive Care Med; 1978 Jan; 4(1):21-7. PubMed ID: 621311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report.
    Br Med J; 1977 Aug; 2(6084):419-21. PubMed ID: 329943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.